Scienture Holdings, Inc. SCNX After the company has partnered with Kindeva, stocks are higher on Thursday. Start znopy.
Must know: Under this agreement, Kindeva will manufacture and supply the old nasal spray, an overdose of opioids. Scienture owns new drug applications and handles US sales, marketing and distribution.
Rezenopy was approved by the Food and Drug Administration on April 19. This is the highest intensity of Naloxone HCL available in the market.
“This collaboration is not to expand its portfolio. It is to make a real difference in the fight against opioid addiction. ” SHANKAR HARIHARANDr. CEO of Scienture. “By working with public health institutions and community organizations, we will lead meaningful changes and save life.”
Also refer to: The $ 1000 invested in this stock five years ago is worth it today.
SCNX price behavior: At the time of writing, Scienture shares are trading at 28.7% higher than $ 2.84. Pro on gasoline.
Image: Through the shutter stock
Do not miss the beat in the stock market. Receive real -time updates for the best stock motion and trading ideas Gasoline as an Indian telegram channel.
© 2025 benzinga.com. Benzinga does not provide investment advice. All rights holdings.
